MFS
CYTK icon

Mirabella Financial Services’s Cytokinetics CYTK Stock Holding History

Mirabella Financial Services’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-37,459
Closed -$3.66M – 518
2023
Q1 		$3.66M Sell
37,459
-31,583
-46% -$1.29M 0.55% 52
2022
Q4 		$3.16M Buy
69,042
+48,899
+243% +$2.1M 0.28% 63
2022
Q3 		$976K Buy
+20,143
New +$969K 0.1% 118
2021
Q4 		– Sell
-7,152
Closed -$256K – 447
2021
Q3 		$256K Buy
+7,152
New +$211K 0.03% 348

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Mirabella Financial Services's CYTK Position: Q2 2023 in Review

Mirabella Financial Services sold out of Cytokinetics (CYTK) in Q2 2023, closing a stake of 37,459 shares — an estimated $3.66M sold.

Mirabella Financial Services first reported a position in CYTK in Q3 2021 and held it in 4 quarters. The position peaked at $3.66M in Q1 2023. 253 funds tracked by Wall St. Rank hold CYTK as of Q2 2023.

  • Mirabella Financial Services reported no remaining Cytokinetics position as of Q2 2023 after selling out during the quarter.
  • Mirabella Financial Services sold 37,459 Cytokinetics shares in Q2 2023, an estimated $3.66M.
  • Mirabella Financial Services first reported a position in Cytokinetics in Q3 2021 and held it in 4 quarters.
  • Mirabella Financial Services's Cytokinetics position peaked at $3.66M in Q1 2023.
  • 253 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2023.

Based on Mirabella Financial Services's 13F filing for Q2 2023, filed 7 Aug 2023.